Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Matthew Bacchetta, MD"'
Autor:
John M. Trahanas, MD, Timothy Harris, MD, Mark Petrovic, MS, Anthony Dreher, MPA, Chetan Pasrija, MD, Stephen A. DeVries, PA-C, Swaroop Bommareddi, MD, Brian Lima, MD, Chen Chia Wang, BSc, Michael Cortelli, BS, Avery Fortier, BSc, Kaitlyn Tracy, MD, Elizabeth Simonds, BA, Clifton D. Keck, Shelley R. Scholl, RN, Hasan Siddiqi, MD, Kelly Schlendorf, MD, Matthew Bacchetta, MD, Ashish S. Shah, MD
Publikováno v:
JTCVS Open, Vol 21, Iss , Pp 197-209 (2024)
Objective: Static cold storage with ice has been the mainstay of cardiac donor preservation. Early preclinical data suggest that allograft preservation at 10 °C may be beneficial. We tested this hypothesis by using a static 10 °C storage device to
Externí odkaz:
https://doaj.org/article/69042baca4bc4a66a144a532d7c5c42f
Autor:
William Tucker, MD, Yatrik Patel, MD, Mark Petrovic, MS, Chris Schwartz, RN, Brandon Petree, DO, Steve Devries, DMSc, PA-C, Brian Lima, MD, John Trahanas, MD, Matthew Bacchetta, MD, MBA, Ashish Shah, MD, Swaroop Bommareddi, MD
Publikováno v:
JHLT Open, Vol 7, Iss , Pp 100163- (2025)
Utilization of 10ºC static storage safely extended both ischemic time and travel radius in heart transplantation. A 57-year-old man with ischemic cardiomyopathy, a left ventricular assist device (LVAD), and end-stage renal disease was listed for com
Externí odkaz:
https://doaj.org/article/d3ea39ebed8d449d8103e97727074f96
Autor:
Wren S. Adkisson, MSN, ACNP-BC, Whitney D. Gannon, MS, MSN, Edward T. Qian, MD, Matthew Bacchetta, MD, MSc, Edward D. Siew, MD, Daniel J. Ford, MSN, AG-ACNP-BC, Janna S. Landsperger, MSN, ACNP-BC, Todd W. Rice, MD, MSc, Jonathan D. Casey, MD, MSc, Matthew W. Semler, MD, MSc, for the Pragmatic Critical Care Research Group
Publikováno v:
Critical Care Explorations, Vol 6, Iss 2, p e1051 (2024)
OBJECTIVES:. For patients with acute respiratory distress syndrome (ARDS) receiving venovenous extracorporeal membrane oxygenation (ECMO) who develop acute kidney injury (AKI) requiring kidney replacement therapy (KRT), the inability to renally compe
Externí odkaz:
https://doaj.org/article/bf59faf0eb1e48ab991fec9d5b71b666
Autor:
Anil J. Trindade, MD, Kaitlyn C. Chapin, AGNP-C, CCTC, Jennifer N. Gray, PharmD, Yuka Furuya, MD, MSCI, Amy Mullican, RN, Haley Hoy, ACNP, PhD, Caitlin T. Demarest, MD, PhD, Ivan M. Robbins, MD, Matthew Bacchetta, MD, MBA, David B. Erasmus, MD, Ciara M. Shaver, MD, PhD
Publikováno v:
Transplantation Direct, Vol 9, Iss 6, p e1487 (2023)
Background. Donor-derived cell-free DNA (dd-cfDNA%) is a biomarker of early acute lung allograft dysfunction (ALAD), with a value of ≥1.0% indicating injury. Whether dd-cfDNA% is a useful biomarker in patients >2 y posttransplant is unknown. Our gr
Externí odkaz:
https://doaj.org/article/711fae669f77454abf6c75532b107e48
Autor:
Anil J. Trindade, MD, Kaitlyn C. Chapin, AGNP, Amy Mullican, RN, Jennifer N. Gray, PharmD, Haley Hoy, AGNP, PhD, Caitlin T. Demarest, MD, PhD, Eric S. Lambright, MD, Katie A. McPherson, MD, Stephanie G. Norfolk, MD, Ivan M. Robbins, MD, Matthew Bacchetta, MD, MBA, David B. Erasmus, MD, Ciara M. Shaver, MD, PhD
Publikováno v:
Transplantation Direct, Vol 8, Iss 12, p e1411 (2022)
Background. Donor-derived cell-free DNA (dd-cfDNA) is a useful biomarker for the diagnosis of acute allograft injury within the first 1 to 2 y after lung transplant, but its utility for diagnosing chronic lung allograft dysfunction (CLAD) has not yet
Externí odkaz:
https://doaj.org/article/f0292f4e8b434720bba0eed3fe2670f5
Autor:
Anil J. Trindade, MD, Whitney D. Gannon, MS, MSN, John W. Stokes, MD, Eric S. Lambright, MD, Katie A. McPherson, MD, Stephanie G. Norfolk, MD, Ivan M. Robbins, MD, Ciara M. Shaver, MD, PhD, Matthew Bacchetta, MD, MBA
Publikováno v:
Transplantation Direct, Vol 8, Iss 10, p e1371 (2022)
Externí odkaz:
https://doaj.org/article/b8473b33ef7d4668b64675b21b711cc8